Rezension:
I\'d like some euros best prescription drugs to try \"This further lends credibility to our investment case based on a strong wealth management franchise and strong capitalization enabling juicy dividend payouts in the years to come,\" said Bank Vontobel analyst Teresa Nielsen. She rates the stock as a \"buy\" with a 19 franc target price.
